Hamps Bio SME IPO Details, Financials, Valuation & Peers
Explore Hamps Bio IPO details, including IPO dates, financial statements, valuation, peer comparison and more.

Overview
Hamps Bio Limited is a diversified company operating in two primary segments: ethical marketing and distribution of pharmaceutical formulation products under the brand name "Hamps," and the manufacturing of freeze-dried and frozen food products under the brand "FzyEzy." The company’s pharmaceutical division provides a wide range of dosage forms, including tablets, syrups, capsules, injectables, oils, gels, and powders, serving both therapeutic and nutrition supplement needs. Simultaneously, the FMCG division focuses on freeze-dried and frozen fruits, vegetables, herbs, and flowers using advanced lyophilization technology. Hamps Bio Limited leverages a robust distribution network of over 50 distributors and prominent e-commerce platforms such as Amazon and Flipkart to market its products across India and internationally. With a portfolio of more than 180 products, the company has a strong presence in the pharmaceutical sector, covering eight Indian states and union territories, and the FMCG sector, spanning 22 states domestically and six countries globally. Hamps Bio Limited has achieved a well-balanced revenue mix with significant growth in its Freeze-Dried and Frozen Products (FDFP) segment, which now contributes 50.40% of total revenue as of October 31, 2024, up from 26.38% in Fiscal 2022, while maintaining consistent performance in its Pharma division.
Key Points:
Pharmaceutical Products Division:
- Ethical Marketing Model:
- Operates through a network of distributors and contract manufacturers with WHO-GMP certified facilities.
- Focuses on providing products in diverse therapeutic areas, including pediatric care, anti-inflammatory drugs, hematinics, and antibiotics.
- Targets specialists such as orthopedic surgeons, gynecologists, and dermatologists.
- Wide Distribution:
- Covers 8,000 doctors and medical stores monthly, achieving sales of approximately 60,000 units each month.
- Operates with a robust team of medical representatives and regional sales managers.
- Focused operations in Gujarat, Maharashtra, Rajasthan, and Madhya Pradesh.
- Brand Strength:
- Portfolio includes 32 established brands and over 100 pharmaceutical products.
- Ethical Marketing Model:
Freeze-Dried and Frozen Products (FDFP) Division:
- Product Portfolio:
- Specializes in freeze-dried fruits, vegetables, herbs, and flowers using lyophilization technology.
- Serves both B2B and B2C segments under the brand “FzyEzy.”
- Dual Business Model:
- Contract Manufacturing: Produces white-label products tailored to customer specifications.
- Own Brand: Markets FDFP products via a dedicated distribution network and leading e-commerce platforms.
- Manufacturing Excellence:
- Operates a state-of-the-art manufacturing unit in Gujarat with advanced freeze-drying capabilities.
- Product Portfolio:
Objects of the Issue
- Purchase of plant & machinery for FMCG division
- Enhancing the visibility and awareness of the brand
- General corporate purposes
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 13 Dec - 17 Dec 2024 |
IPO Price Band | ₹51 per share |
Fresh Issue | ₹6.22 crore |
Offer For Sale | NIL |
Total IPO Size | ₹6.22 crore |
Face Value | ₹10 |
Listing On | BSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 13 Dec 2024 |
IPO Closing Date | 17 Dec 2024 |
Basis Of Allotment | 18 Dec 2024 |
Refunds | 19 Dec 2024 |
Demat Transfer | 19 Dec 2024 |
IPO Listing Date | 20 Dec 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Oct 2024 |
---|---|---|---|---|
Total Income | 5.34 | 5.58 | 6.50 | 4.36 |
Total Expenses | 5.24 | 5.23 | 5.85 | 3.90 |
Net Profit/Loss | 0.12 | 0.36 | 0.50 | 0.34 |
NPM (*) | 2.28 | 6.44 | 7.73 | 7.99 |
Total Assets | 3.64 | 3.96 | 5.15 | 6.44 |
Total Liabilities | 2.64 | 2.60 | 1.77 | 2.73 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Oct 2024 |
---|---|---|---|---|
EPS | 0.51 | 1.50 | 1.76 | 1.09 |
ROE (%) | 12.32 | 30.31 | 21.14 | 16.65 |
ROCE (%) | 9.76 | 17.43 | 18.31 | 18.53 |
D/E Ratio | 2.03 | 1.27 | 0.31 | 0.37 |
Current Ratio | 0.74 | 0.59 | 1.73 | 1.38 |
EBITDA MARGIN (%) | 11.52 | 15.53 | 18.18 | 15.32 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
No listed peers available for comparison.
Subscription Data from NSE and BSE
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 0 |
Non-Institutional Investor (NII/HNI) | 758.27 |
Retail Individual Investor (RII) | 1342.04 |
Total | 1057 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
Bigshare Services Private Limited
Phone: +91 22-62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Company Promoters
- HERRIK SHAH
- SHRENIK SHAH
- PALLAVI SHAH
- MITALI SHAH
- HERRIK SHAH HUF
- SHRENIK SHAH HUF
Lead Managers
- MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED
Company Address
Hamps Bio Limited
2900/112, GIDC, Near Atul Limited, Ankelshwar, Bharuch – 393 002, Gujarat, India.
Phone: +91 8000006663
Email: info@hampsbio.com
Website: www.hampsbio.com
FAQs
- What is the issue size of the Hamps Bio SME IPO?The Hamps Bio SME IPO has an issue size of ₹6.22 crore. This includes a fresh issue of ₹6.22 crore and an offer for sale (OFS) of NIL.
- What is the price band of the Hamps Bio IPO?The price band for the Hamps Bio IPO is ₹51 per share.
- What are the bidding dates for the Hamps Bio IPO?The Hamps Bio IPO will open for bidding on 13 Dec 2024 and close on 17 Dec 2024.
- What is the allotment date for the Hamps Bio IPO?The allotment date for the Hamps Bio IPO is 18 Dec 2024.
- What is the minimum lot size and investment required for the Hamps Bio IPO?The minimum lot size for the Hamps Bio IPO is 2000 shares and the minimum investment required is ₹1,02,000.
- What is the listing date for the Hamps Bio IPO?The listing date for the Hamps Bio IPO is 20 Dec 2024.
- What is the Hamps Bio IPO grey market premium?The grey market premium (GMP) for the Hamps Bio IPO is currently at ₹60, with an expected listing gain of approximately 117.65%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.